Benzinga | Aug 11, 2020 05:47AM EDT

Piper Sandler Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $55

Piper Sandler analyst Christopher Raymond initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $55.